KRAS also supports metastatic dissemination through repression of Raf Kinase Inhibitory Protein (RKIP), a putative tumor suppressor with roles in cell migration, motility, and epithelial-to-mesenchymal transition (73). The gene discussed is PEBP1; the disease is neoplasm.